Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

204 ARTÍCULOS , VIENDO DEL 166 AL 180

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease

Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.

Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.

Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology

Uddin MS, Al Mamun A, Kabir MT, Jakaria M, Mathew B, Barreto GE, Ashraf GM.

Mol Neurobiol. 2019 Jul;56(7):4925-4944. doi: 10.1007/s12035-018-1420-2. Epub 2018 Nov 9.

Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease

Morsy A, Trippier PC.

J Med Chem. 2019 May 9;62(9):4252-4264. doi: 10.1021/acs.jmedchem.8b01530. Epub 2018 Nov 30.

Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly

Lee BI, Chung YJ, Park CB.

Biomaterials. 2019 Jan;190-191:121-132. doi: 10.1016/j.biomaterials.2018.10.043. Epub 2018 Oct 30.

Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease

Pradeepkiran JA, Reddy AP, Reddy PH.

Drug Discov Today. 2019 Feb;24(2):616-623. doi: 10.1016/j.drudis.2018.11.005. Epub 2018 Nov 16.

Comparison of Cognitive Intervention Strategies for Older Adults With Mild to Moderate Alzheimer's Disease: A Bayesian Meta-analytic Review

Liang JH, Li JY, Jia RX, Wang YQ, Wu RK, Zhang HB, Hang L, Xu Y, Pan CW.

J Am Med Dir Assoc. 2019 Mar;20(3):347-355. doi: 10.1016/j.jamda.2018.09.017. Epub 2018 Nov 17.

Efficacy of Cognitive Rehabilitation in Alzheimer Disease: A 1-Year Follow-Up Study

Germain S, Wojtasik V, Lekeu F, Quittre A, Olivier C, Godichard V, Salmon E.

J Geriatr Psychiatry Neurol. 2019 Jan;32(1):16-23. doi: 10.1177/0891988718813724. Epub 2018 Nov 26.

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Camins A, Ettcheto M, Busquets O, Manzine PR, Castro-Torres RD, Beas-Zarate C, Verdaguer E, Sureda FX, Bulló M, Olloquequi J, Auladell C, Folch J.

Expert Opin Investig Drugs. 2019 Jan;28(1):93-97. doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1.

Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines

Bartolini M, Marco-Contelles J.

Chem Rec. 2019 May;19(5):927-937. doi: 10.1002/tcr.201800155. Epub 2018 Nov 29.

New approaches for the treatment of Alzheimer's disease

Fish PV, Steadman D, Bayle ED, Whiting P.

Bioorg Med Chem Lett. 2019 Jan 15;29(2):125-133. doi: 10.1016/j.bmcl.2018.11.034. Epub 2018 Nov 19.

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Wang H, Zhang H.

ACS Chem Neurosci. 2019 Feb 20;10(2):852-862. doi: 10.1021/acschemneuro.8b00391. Epub 2018 Dec 6.

Feasibility and Impact of a Multicomponent Exercise Intervention in Patients With Alzheimer's Disease: A Pilot Study

Borges-Machado F, Ribeiro Ó, Sampaio A, Marques-Aleixo I, Meireles J, Carvalho J.

Am J Alzheimers Dis Other Demen. 2019 Mar;34(2):95-103. doi: 10.1177/1533317518813555. Epub 2018 Dec 9.

Translating the biology of aging into novel therapeutics for Alzheimer disease

Hara Y, McKeehan N, Fillit HM.

Neurology. 2019 Jan 8;92(2):84-93. doi: 10.1212/WNL.0000000000006745. Epub 2018 Dec 7.

Structure-Based Survey of the Binding Modes of BACE1 Inhibitors

Hu H, Chen Z, Xu X, Xu Y.

ACS Chem Neurosci. 2019 Feb 20;10(2):880-889. doi: 10.1021/acschemneuro.8b00420. Epub 2018 Dec 27.

Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies

Nisticò R, Peineau S.

Pharmacol Res. 2019 Jan;139:467-468. doi: 10.1016/j.phrs.2018.12.011. Epub 2018 Dec 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias